CD Biosynsis offers end-to-end Vibrio natriegens Genome Editing and Metabolic Engineering Solutions, providing a complete platform for developing high-performance production strains in this ultra-fast host. V. natriegens is recognized as the fastest microbial chassis, with a doubling time of approximately 10 min, fundamentally accelerating industrial strain development. Our solutions integrate cutting-edge CRISPR-based genome editing tools (knockout, knock-in, base editing, and CRISPRi) with rational design methodologies (metabolic modeling and high-throughput screening). We handle the entire engineering process, from initial target identification and pathway optimization to final strain stability validation, guaranteeing the rapid and successful development of V. natriegens strains for superior biomanufacturing productivity.
Get a QuoteThe core challenge in industrial biotechnology is the speed of strain development. By combining the rapid growth kinetics of V. natriegens with a unified set of advanced engineering and screening tools, we turn the slow, iterative process into a fast, data-driven cycle. Our platform ensures that modifications are not only precise but also strategically optimized to manage the high metabolic flux inherent in this host's dual-chromosome system, enabling maximal product yield, faster scale-up, and superior industrial performance.
Comprehensive services covering all types of modification: large knock-ins (KI), clean deletions (KO), and regulatory element tuning.
Multiplexed CRISPR strategies for the simultaneous or sequential elimination of 2-10 competing genes, ensuring efficient flux redirection.
Base Editing & CRISPRi
Tools for subtle, non-lethal tuning of gene expression: Base Editing for point mutations and CRISPRi for reversible gene knockdown.
Systematic optimization of biosynthetic pathways, focusing on balancing enzyme expression, eliminating bottlenecks, and maximizing product titer.
Rapid, automated high-throughput screening (HTS) and iterative optimization to quickly evolve complex engineered strains for optimal performance.
Chassis Engineering
Modification of the V. natriegens host to improve tolerance to stress, broaden feedstock utilization, and establish biosafety features (auxotrophy).
Computational prediction (CBM) and experimental verification (Fluxomics) to guide rational design and ensure data-driven decision-making.
High-speed, large-scale production and purification of recombinant enzymes and therapeutic proteins using the V. natriegens host system.
Fermentation Scale-Up Support
Optimization of media and cultivation parameters (HCDC, feeding strategies) to prepare the final engineered strain for large-scale industrial bioreactors.
A seamless, project-based pathway from rational design to industrial strain readiness.
1. Rational Target Identification
2. Precision Genomic Modification
3. High-Throughput Phenotyping
4. Scale-Up & Final Delivery
Utilize metabolic modeling (Assay & Modeling) to analyze the existing V. natriegens strain and identify limiting factors or competing pathways.
Design a comprehensive strategy including KO, KI, and regulatory tuning targets for maximum product yield.
Define HTS assay metrics and screening thresholds.
Apply optimized CRISPR-based tools (Genome Editing) to construct rationally designed strain variants or libraries.
Perform multi-gene knockouts and stable chromosomal knock-ins of entire biosynthetic pathways.
Ensure all edits are markerless and verified genotypically.
Stabilize the final engineered production strain (Markerless and Chromosomally Integrated).
Provide support for fermentation parameter optimization (Scale-Up Support).
Deliver the verified, industrial-ready V. natriegens production strain and all associated data.
Unmatched Time Savings
The synergy between V. natriegens's 10-minute doubling time and our integrated HTS platform drastically reduces strain optimization timelines by up to 50% compared to traditional hosts.
Unified Toolset
Single-platform access to all necessary tools: Modeling for Design, CRISPR for Build, HTS/Assay for Test/Learn, ensuring seamless integration and maximal project velocity.
Dual-Chromosome Expertise
Specialized protocols for editing, integrating, and optimizing pathways across V. natriegens's complex two-chromosome system, ensuring optimal flux distribution and stability.
Industrial Readiness
Focus on generating markerless, chromosomally integrated strains, validated under HCDC conditions, guaranteeing genetic stability and immediate suitability for large-scale fermentation.
1. What is the biggest advantage V. natriegens offers for biomanufacturing?
The greatest advantage is its doubling time of approximately 10 minutes, allowing for extremely high volumetric productivity (product per volume per time) and significantly accelerated strain development and optimization cycles.
2. How do you ensure the stability of the engineered pathway?
We prioritize stable chromosomal integration of the entire biosynthetic pathway into safe harbor sites on V. natriegens's chromosomes, ensuring the pathway is not lost during the host's rapid cell division cycles.
3. Does the Base Editing tool work on both V. natriegens chromosomes?
Yes. Our Base Editing gRNA designs are specifically optimized to successfully target and modify loci on both Chromosome I and Chromosome II, providing precise control across the entire genome.
4. Is metabolic modeling (CBM) required for every project?
Modeling is highly recommended as it provides a rational foundation for the engineering strategy, predicting bottlenecks and optimal edits. While not strictly required for simple projects, it ensures the highest chance of success for complex pathway optimization.
5. What is the role of High-Throughput Screening (HTS) in the process?
HTS is crucial for the rapid evaluation of thousands of engineered strain variants (libraries), allowing us to quickly identify the best performing clones under relevant industrial conditions, utilizing V. natriegens's speed advantage.
6. Can you optimize the host for tolerance to high concentrations of product?
Yes. We use adaptive laboratory evolution and targeted genome editing to modify genes related to efflux pumps or stress response, significantly improving the strain's ability to tolerate high titers of the target product.
7. What is included in the final delivery package?
The final delivery includes the optimized V. natriegens production strain, a full report detailing all genetic modifications and performance data (titer, yield), and the finalized metabolic model used for the optimization.
8. Are the expressed proteins from the V. natriegens host properly folded and functional?
Yes. While V. natriegens is a prokaryote, its unique proteostasis machinery often allows for superior folding of certain proteins compared to E. coli. We perform rigorous functional assays to ensure the delivered protein meets activity specifications.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.